Matches in SemOpenAlex for { <https://semopenalex.org/work/W1991551158> ?p ?o ?g. }
- W1991551158 endingPage "241" @default.
- W1991551158 startingPage "235" @default.
- W1991551158 abstract "Recent immunotherapy depends largely on understanding of the molecular interactions between T cell receptors (TCR) on cytotoxic T lymphocytes (CTL) and peptide/MHC class I complexes on tumor cells. Many tumor antigens identified by cDNA library expression cloning methods, especially from malignant melanoma, have greatly contributed to clarifying such mechanisms and led to peptide vaccination trials, mainly for patients with melanoma. Although the objective tumor regression rate mediated by peptide vaccination is still low compared to adoptive cell transfer therapy, antigenic peptide vaccination can cause a constant objective response generally evaluated as stable disease or decreased serum levels of tumor markers. In addition, recent trials in the adjuvant setting showed some suppressive effects against recurrence. Therefore, peptide vaccination still has potential for clinical benefits in patients with various cancers. For further improvement of peptide vaccination, we considered that (i) novel antigenic peptides, (ii) effective adjuvants, (iii) more sensitive immunological monitoring and (iv) drugs up-regulating HLA class I molecules might be important. Keywords: Peptide vaccination, tumor-associated antigen, CTL epitope, clinical trial" @default.
- W1991551158 created "2016-06-24" @default.
- W1991551158 creator A5000123851 @default.
- W1991551158 creator A5004878380 @default.
- W1991551158 creator A5012199991 @default.
- W1991551158 creator A5041768161 @default.
- W1991551158 creator A5061830609 @default.
- W1991551158 creator A5065666450 @default.
- W1991551158 creator A5065838675 @default.
- W1991551158 creator A5072637751 @default.
- W1991551158 creator A5081710951 @default.
- W1991551158 date "2008-11-01" @default.
- W1991551158 modified "2023-10-16" @default.
- W1991551158 title "Antigenic Peptide Vaccination: Provoking Immune Response and Clinical Benefit for Cancer" @default.
- W1991551158 cites W1484893812 @default.
- W1991551158 cites W1572267688 @default.
- W1991551158 cites W1807891428 @default.
- W1991551158 cites W1904176663 @default.
- W1991551158 cites W1954532037 @default.
- W1991551158 cites W1963597390 @default.
- W1991551158 cites W1966936031 @default.
- W1991551158 cites W1967425011 @default.
- W1991551158 cites W1983412131 @default.
- W1991551158 cites W1983806918 @default.
- W1991551158 cites W1985265825 @default.
- W1991551158 cites W1988475638 @default.
- W1991551158 cites W1989548072 @default.
- W1991551158 cites W1992699637 @default.
- W1991551158 cites W1995009388 @default.
- W1991551158 cites W1999971211 @default.
- W1991551158 cites W2006198332 @default.
- W1991551158 cites W2006987944 @default.
- W1991551158 cites W2015533428 @default.
- W1991551158 cites W2024824954 @default.
- W1991551158 cites W2024872180 @default.
- W1991551158 cites W2034108561 @default.
- W1991551158 cites W2036408747 @default.
- W1991551158 cites W2037665874 @default.
- W1991551158 cites W2038032899 @default.
- W1991551158 cites W2047127667 @default.
- W1991551158 cites W2047392100 @default.
- W1991551158 cites W2050933039 @default.
- W1991551158 cites W2055399016 @default.
- W1991551158 cites W2060688081 @default.
- W1991551158 cites W2063640902 @default.
- W1991551158 cites W2067712862 @default.
- W1991551158 cites W2070436392 @default.
- W1991551158 cites W2070660250 @default.
- W1991551158 cites W2073114277 @default.
- W1991551158 cites W2076730875 @default.
- W1991551158 cites W2077450760 @default.
- W1991551158 cites W2078543306 @default.
- W1991551158 cites W2078684250 @default.
- W1991551158 cites W2080335579 @default.
- W1991551158 cites W2082463658 @default.
- W1991551158 cites W2088224060 @default.
- W1991551158 cites W2094652659 @default.
- W1991551158 cites W2095224835 @default.
- W1991551158 cites W2098852858 @default.
- W1991551158 cites W2099597598 @default.
- W1991551158 cites W2101030466 @default.
- W1991551158 cites W2103018035 @default.
- W1991551158 cites W2109898906 @default.
- W1991551158 cites W2114060340 @default.
- W1991551158 cites W2114064307 @default.
- W1991551158 cites W2115148392 @default.
- W1991551158 cites W2116914257 @default.
- W1991551158 cites W2117216774 @default.
- W1991551158 cites W2122476064 @default.
- W1991551158 cites W2128192445 @default.
- W1991551158 cites W2128897591 @default.
- W1991551158 cites W2130542755 @default.
- W1991551158 cites W2136268849 @default.
- W1991551158 cites W2138163780 @default.
- W1991551158 cites W2140451216 @default.
- W1991551158 cites W2141985710 @default.
- W1991551158 cites W2142190430 @default.
- W1991551158 cites W2143857111 @default.
- W1991551158 cites W2143992630 @default.
- W1991551158 cites W2147103876 @default.
- W1991551158 cites W2148226248 @default.
- W1991551158 cites W2148523692 @default.
- W1991551158 cites W2151246207 @default.
- W1991551158 cites W2153512326 @default.
- W1991551158 cites W2157078337 @default.
- W1991551158 cites W2160747045 @default.
- W1991551158 cites W2161585699 @default.
- W1991551158 cites W2161763283 @default.
- W1991551158 cites W2161872048 @default.
- W1991551158 cites W2163242247 @default.
- W1991551158 cites W2163406401 @default.
- W1991551158 cites W2164614740 @default.
- W1991551158 cites W2169625332 @default.
- W1991551158 cites W2192676359 @default.
- W1991551158 cites W2324304000 @default.
- W1991551158 cites W2470158745 @default.
- W1991551158 doi "https://doi.org/10.2174/157339508786447959" @default.
- W1991551158 hasPublicationYear "2008" @default.